切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2016, Vol. 02 ›› Issue (04) : 245 -247. doi: 10.3877/cma.j.issn.2095-9141.2016.04.013

所属专题: 文献

专题笔谈

重视对重型颅脑损伤后沉默的30%的研究和治疗
陈前伟1, 谭亮1, 尹怡1, 冯华1,()   
  1. 1. 400038 重庆,第三军医大学西南医院神经外科,全军神经外科研究所,全军神经创伤防治重点实验室,重庆市脑科学协同创新中心
  • 收稿日期:2016-01-23 出版日期:2016-08-15
  • 通信作者: 冯华
  • 基金资助:
    国家重点基础研究发展计划(973计划(2014CB541606)

Pay attention to the 30% silent after severe traumatic brain injury

Qianwei Chen1, Liang Tan1, Yi Yin1, Hua Feng1,()   

  1. 1. Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
  • Received:2016-01-23 Published:2016-08-15
  • Corresponding author: Hua Feng
  • About author:
    Corresponding author: Feng Hua, Email:
引用本文:

陈前伟, 谭亮, 尹怡, 冯华. 重视对重型颅脑损伤后沉默的30%的研究和治疗[J]. 中华神经创伤外科电子杂志, 2016, 02(04): 245-247.

Qianwei Chen, Liang Tan, Yi Yin, Hua Feng. Pay attention to the 30% silent after severe traumatic brain injury[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2016, 02(04): 245-247.

颅脑损伤大多数为轻型伤与中型伤。伤后过程,轻型伤无颅骨骨折者约有0.2%~0.7%的患者加重;有颅骨骨折者3.2%~10%病情转恶化。中型伤有一部分脑挫裂伤患者,数日内出现迟发性颅内血肿。这两类患者如有明显症状,宜住院观察治疗避免发生意外。重型颅脑损伤约占颅脑伤的20%,死亡率很高,是救治的重点。颅脑创伤患者的死亡率下降了50个百分点,具有明显的进步。另外一个有意思的发现是1885~1930年,颅脑创伤死亡率以每10年3个百分点的速度下降,而在1930~1970年期间死亡率无明显增减,1970~1990年出现了死亡率的迅速下降,达到了平均每10年9.2个百分点,而1990~2006年间颅脑创伤死亡率再次出现了平台期,约占病例总数的30%。可以很明显地看到脑外伤死亡率的两次明显下降之后又处在平台期。分析了这种变化趋势背后所采取的救治策略的价值,提出未来应该重视对于救治这沉默的30%颅脑创伤死亡患者的研究和治疗。

Most of the head injuries were light and medium-sized injuries. After injury, about 0.2% to 0.7% of the light injury without skull fracture patients will be aggravated; 3.2%~10% of the patients with skull fracture will be worse. One part of the middle injury patients were brain contusion, and the symptoms of delayed intracranial hematoma occurred several days later. If these two categories of patients with obvious symptoms, then it should be hospitalized for treatment to avoid accidents. If these two categories of patients with obvious symptoms, then it should be hospitalized for treatment to avoid accidents. Severe brain injury accounts for about 20% of the brain injury, the mortality rate is very high, so it is the focus of our treatment. The death rate of patients with traumatic brain injury has been reduced by 50 percentage points, which has made remarkable progress. Another interesting discovery is that, during 1885 to 1930, the mortality of craniocerebral trauma at a rate of 3 percent for every 10 years of decline; and in 1930~1970 years mortality did not increase or decrease obviously; from 1970 to 1990, mortality decreased rapidly to average every 10 years 9.2 percentage points; and in 1990 to 2006, the platform of craniocerebral trauma mortality appears again, accounting for about 30% of the total cases. We can clearly see that there is a plateau in the mortality of brain injury after the two significant decline. After analyzing this trend, we should pay more attention to the research and treatment of 30% patients with brain trauma.

[1]
Andelic N. The epidemiology of traumatic brain injury[J]. Lancet Neurol, 2013, 12(1): 28-29.
[2]
Jennett B. Epidemiology of head injury[J]. Arch Dis Child, 1998, 78(5): 403-406.
[3]
Stein SC,Georgoff P,Meghan S, et al. 150 years of treating severe traumatic brain injury: A systematic review of progress in mortality[J]. J Neurotrauma, 2010, 27(7): 1343-1353.
[4]
Rosenfeld JV,Maas AI,Bragge P, et al. Early management of severe traumatic brain injury[J]. Lancet, 2012, 380: 1088-1098.
[5]
Verchère J,Blanot S,Vergnaud E, et al. Mortality in severe traumatic brain injury[J]. Lancet Neurol, 2013, 12: 426-427.
[6]
Maas AI,Stocchetti N,Bullock R. Moderate and severe traumatic brain injury in adults[J]. Lancet Neurol, 2008, 7(8): 728-741.
[7]
Jacobs B,Beems T,van der Vliet TM, et al. Computed tomography and outcome in moderate and severe traumatic brain injury: Hematoma volume and midline shift revisited[J]. J Neurotrauma, 2011, 28(2): 203-215.
[8]
Farahvar A,Gerber LM,Chiu YL, et al. Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring[J]. J Neurosurg, 2012, 117: 729-734.
[9]
Chesnut RM,Temkin N,Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury[J]. N Engl J Med, 2012, 367: 2471-2481.
[10]
Carney N,Lujan S,Dikmen S, et al. Intracranial pressure monitoring in severe traumatic brain injury in latin america: Process and methods for a multi-center randomized controlled trial[J]. J Neurotrauma, 2012, 29(11): 2022-2029.
[11]
Meyfroidt G. Intracranial pressure monitoring in severe traumatic brain injury: The time for a randomized controlled trial is now[J]. Crit Care Med, 2012, 40(6): 1993-1994.
[12]
Melhem S,Shutter L,Kaynar A. A trial of intracranial pressure monitoring in traumatic brain injury[J]. Crit Care, 2014, 18(1): 302.
[13]
Murillo-Cabezas F,Godoy DA. Intracranial pressure monitoring in severe traumatic brain injury: A different perspective of the besttrip trial[J]. Med Intensiva, 2014, 38(4): 237-239.
[14]
Sarrafzadeh AS,Smoll NR,Unterberg AW. Lessons from the intracranial pressure-monitoring trial in patients with traumatic brain injury[J]. World Neurosurg, 2014, 82(1-2): e393-395.
[15]
Hawthorne C,Piper I. Monitoring of intracranial pressure in patients with traumatic brain injury[J]. Front Neurol, 2014, 5: 121.
[16]
Nangunoori R,Maloney-Wilensky E,Stiefel M, et al. Brain tissue oxygen-based therapy and outcome after severe traumatic brain injury: A systematic literature review[J]. Neurocrit Care, 2012, 17(1): 131-138.
[17]
Rosenthal G,Furmanov A,Itshayek E, et al. Assessment of a noninvasive cerebral oxygenation monitor in patients with severe traumatic brain injury[J]. J Neurosurg, 2014, 120(4): 901-907.
[18]
Haddad SH,Arabi YM. Critical care management of severe traumatic brain injury in adults[J]. Scand J Trauma Resusc Emerg Med, 2012, 20: 12.
[19]
Timofeev I,Carpenter KL,Nortje J, et al. Cerebral extracellular chemistry and outcome following traumatic brain injury: A microdialysis study of 223 patients[J]. Brain, 2011, 134(Pt2): 484-494.
[20]
Kennedy RT. Emerging trends in in vivo neurochemical monitoring by microdialysis[J]. Curr Opin Chem Biol, 2013, 17(5): 860-867.
[21]
Nordström CH,Reinstrup P,Xu W, et al. Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional enegy metabolism[J]. Anesthesiology, 2003, 98(4): 809-814.
[22]
Hlatky R,Valadka AB,Goodman JC, et al. Patterns of energy substrates during ischemia measured in the brain by microdialysis[J]. J Neurotrauma, 2004, 21(7): 894-906.
[23]
Dienel GA. Lactate shuttling and lactate use as fuel after traumatic brain injury: Metabolic considerations[J]. J Cereb Blood Flow Metab, 2014, 34(11): 1736-1748.
[24]
Baines CP,Kaiser RA,Purcell NH, et al. Loss of cyclophilin d reveals a critical role for mitochondrial permeability transition in cell death[J]. Nature, 2005, 434(7033): 658-662.
[25]
Marechal X,Montaigne D,Marciniak C, et al. Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics[J]. Clin Sci (Lond), 2011, 121(9): 405-413.
[1] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[2] 黄珞, 梁爱琳, 龚启梅. 线粒体动力学在牙源性间充质干细胞中的研究现状[J]. 中华口腔医学研究杂志(电子版), 2022, 16(06): 352-357.
[3] 李晖, 范志勇, 耿西林, 常虎林, 吴武军, 张煜. 肝癌中线粒体膜蛋白ATAD3A表达与临床病理特征及预后的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 157-161.
[4] 邵浩仁, 郭佳. 铁死亡的分子机制及其在前列腺癌治疗中的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 294-298.
[5] 张馨月, 韩帅, 张舒石, 李文臣, 张舒岩. 颅内压监测技术在创伤性颅脑损伤治疗中的应用[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 246-252.
[6] 程岗. "融合"理念在军队颅脑创伤亚专科人才培养中的意义[J]. 中华神经创伤外科电子杂志, 2023, 09(01): 48-50.
[7] 张华, 刘广明, 刘国成, 张姝红, 陈大莉, 蒲小龙, 王志友, 李倩. 基于决策树法构建创伤性颅脑损伤术后硬脑膜下积液的风险预测模型[J]. 中华神经创伤外科电子杂志, 2023, 09(01): 19-25.
[8] 张付意, 侯现增, 汪建军, 辛涛. 有创颅内压监测靶向管控在重型颅脑损伤患者围术期应用价值分析[J]. 中华神经创伤外科电子杂志, 2022, 08(05): 298-301.
[9] 阳莹, 崔亚梅, 邵强, 赵宁, 陶文强, 陈家泉, 徐泽尧, 钱克俭, 刘芬. 线粒体自噬对肺泡巨噬细胞焦亡的调控作用及其机制[J]. 中华重症医学电子杂志, 2023, 09(01): 69-77.
[10] 刘政委, 仪立志, 尹夕龙, 孔文龙, 纠智松, 张文源. 锥颅血肿外引流与神经内镜手术治疗老年基底节区高血压性脑出血的疗效分析[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 299-303.
[11] 王煜泽, 高文文, 杨磊, 赵海康. 无创监测技术在脑水肿应用的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(02): 113-117.
[12] 刘性强, 王文豪, 白映红, 李存晓, 李斌. 二甲双胍下调水通道蛋白4表达改善大鼠颅脑创伤早期脑水肿的研究[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(04): 221-226.
[13] 于乾雪, 廖学梅, 孙龙龙, 范梦莹, 蒋明超, 孟慧, 李瑞基. 线粒体功能障碍与卵巢早衰的研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 283-288.
[14] 于露, 李永华. 线粒体相关内质网膜的生物学功能及其在相关疾病中作用的研究进展[J]. 中华诊断学电子杂志, 2022, 10(04): 284-288.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要